Florian Huemer

Florian Huemer is a Senior Lecturer in the Department of Internal Medicine III at the University of Salzburg, specializing in Hematology, Medical Oncology, and Oncologic Research. His work focuses on advanced cancer therapies, including targeted therapies, immunotherapy, and molecular subtyping in colorectal, pancreatic, and lung cancers. He has led or co-led multiple research projects investigating tumor dynamics, treatment responses, and clinical outcomes. Key initiatives include studies on consensus molecular subtyping in rectal cancer, clonal heterogeneity assessment via liquid biopsies, and the impact of antibiotic use on immunotherapy efficacy.

Research interests span oncology, immuno-oncology, and translational medicine, with a focus on improving personalized treatment strategies. Notable contributions include analyses of chemotherapy sequencing in pancreatic cancer and the long-term survival outcomes of small cell lung cancer patients treated with atezolizumab. Collaborations with institutions like the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie) and international trials (e.g., IMpower133) underscore his commitment to advancing clinical oncology.

His projects emphasize translational research, bridging genomic analysis, imaging, and clinical practice. He has published extensively on topics such as tumor microenvironment modulation, immune contexture changes, and biomarker-driven therapy selection. Recent work highlights the integration of single-cell technologies and spatial biology to understand tumor heterogeneity.

Florian Huemer has advised on multiple clinical studies and contributed to retrospective analyses of treatment patterns in Austria, including the PRATER study on non-small cell lung cancer care pathways. His research has been referenced in peer-reviewed journals and platforms like Mendeley, reflecting its impact on the scientific community.